Chemoinformaics analysis of Iriflophenone Glucoside
| Molecular Weight | 408.359 | nRot | 4 |
| Heavy Atom Molecular Weight | 388.199 | nRig | 19 |
| Exact Molecular Weight | 408.106 | nRing | 3 |
| Solubility: LogS | -2.777 | nHRing | 1 |
| Solubility: LogP | -0.22 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 2 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 12 |
| nHA | 10 | APOL | 53.0859 |
| nHD | 8 | BPOL | 22.6681 |
| QED | 0.299 |
| Synth | 3.852 |
| Natural Product Likeliness | 1.786 |
| NR-PPAR-gamma | 0.85 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.068 |
| HIA | 0.908 |
| CACO-2 | -6.297 |
| MDCK | 0.00000508 |
| BBB | 0.092 |
| PPB | 0.952067 |
| VDSS | 0.802 |
| FU | 0.0776291 |
| CYP1A2-inh | 0.043 |
| CYP1A2-sub | 0.027 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.051 |
| CYP2c9-inh | 0.009 |
| CYP2c9-sub | 0.357 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.153 |
| CYP3a4-inh | 0.044 |
| CYP3a4-sub | 0.025 |
| CL | 6.009 |
| T12 | 0.551 |
| hERG | 0.046 |
| Ames | 0.776 |
| ROA | 0.084 |
| SkinSen | 0.23 |
| Carcinogencity | 0.065 |
| EI | 0.027 |
| Respiratory | 0.025 |
| NR-Aromatase | 0.799 |
| Antiviral | Yes |
| Prediction | 0.743744 |